Cite
MLA Citation
Xiaoxia Chen et al.. “A phase 2 study of sorafenib combined with conventional therapies in refractory central nervous system leukemia.” Cancer, vol. 128, no. 11, 2022, pp. 2138–2147. http://access.bl.uk/ark:/81055/vdc_100154264133.0x000030